AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Novavax (NVAX) stock forecast for 2022
The forecast has been updated: September 15, 2022 12:21
Novavax stock price online today
Analyst Target Price
121.6Dividend Date
10.05.2019Ex Dividend Date
-Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Novavax stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Novavax stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $121.6 target price for Novavax stock stock.
Today 200 Day Moving Average is the resistance level (79.82 $).
50 Day Moving Average is the resistance level (48.9 $).
NVAX Forecast for 2022
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Oct | 29.62 | 25.44 | 32.64 | 22.05 % |
| Nov | 34.95 | 27.82 | 39.99 | 30.42 % |
| Dec | 39.67 | 32.41 | 48.36 | 32.98 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novavax stock.
Novavax overview
Novavax Address
20 FIRSTFIELD ROAD, GAITHERSBURG, MD, USMarket Capitalization
2 581 098 000 $EBITDA
-1 384 364 032PE Ratio
NonePEG Ratio
0Dividend Per Share
0Dividend Yield
0EPS
-17.51Quarterly Earnings Growth YOY
0Quarterly Revenue Growth YOY
-0.376Trailing PE
-Forward PE
0.981EV To Revenue
0.799EV To EBITDA
-1.02552 Week High
260.6952 Week Low
28.2550 Day Moving Average
48.9200 Day Moving Average
79.82Shares Outstanding
78215000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Novavax stock forecast for this year
Novavax stock forecast for Oct 2022.
Estimated Average Forecasted Novavax Price: 29.62. Positive monthly dynamics of the instrument is expected with 22.051% volatility is expected.
Pessimistic forecast: 25.44
Optimistic: 32.64
Novavax stock forecast for Nov 2022.
Estimated Average Forecasted Novavax Price: 34.95. Positive monthly dynamics of the instrument is expected with 30.420% volatility is expected.
Pessimistic forecast: 27.82
Optimistic: 39.99
Novavax stock forecast for Dec 2022.
Estimated Average Forecasted Novavax Price: 39.67. Positive monthly dynamics of the instrument is expected with 32.978% volatility is expected.
Pessimistic forecast: 32.41
Optimistic: 48.36
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
 Abbott Laboratories
|
ABT | 102.31 (20.09.2022) | -1.71 % |
 AbbVie Inc.
|
ABBV | 141.77 (20.09.2022) | -0.62 % |
 Aeterna Zentaris Inc.
|
AEZS | 4.55 (19.09.2022) | 0.66 % |
 Allakos Inc.
|
ALLK | 5.55 (20.09.2022) | -4.97 % |
 Allogene Therapeutics, Inc.
|
ALLO | 13.35 (20.09.2022) | 1.44 % |
 Amgen Inc.
|
AMGN | 227.71 (20.09.2022) | -1.32 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 3.8 (20.09.2022) | -0.26 % |
 Aurora Cannabis Inc.
|
ACB | 1.4 (20.09.2022) | -4.76 % |
 Becton Dickinson and Company
|
BDX | 244.11 (20.09.2022) | -2.85 % |
 Biogen Inc.
|
BIIB | 204.2 (20.09.2022) | -2.42 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 151.25 (20.09.2022) | 0.03 % |
 BioNTech SE
|
BNTX | 133.46 (20.09.2022) | 0.18 % |
 bluebird bio, Inc.
|
BLUE | 6.86 (20.09.2022) | 15.68 % |
 Boston Scientific Corp.
|
BSX | 40.43 (20.09.2022) | -1.82 % |
 Bristol-Myers Squibb Company
|
BMY | 69.73 (20.09.2022) | -0.66 % |
 Canopy Growth Corp.
|
CGC | 3.08 (20.09.2022) | -4.64 % |
 Castle Biosciences, Inc.
|
CSTL | 26.51 (20.09.2022) | 2.71 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
 Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
 Emergent BioSolutions Inc.
|
EBS | 21.79 (20.09.2022) | -3.16 % |
 Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
 G1 Therapeutics, Inc.
|
GTHX | 14.25 (20.09.2022) | 1.79 % |
 Gilead Sciences, Inc.
|
GILD | 64.58 (20.09.2022) | -1.88 % |
 GlaxoSmithKline plc
|
GSK | 30.49 (20.09.2022) | -0.94 % |
 GoodRx Holdings, Inc.
|
GDRX | 5.71 (20.09.2022) | -2.56 % |
 GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 68.26 (20.09.2022) | -0.80 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 1.87 (20.09.2022) | 1.08 % |
 Johnson & Johnson
|
JNJ | 164.97 (20.09.2022) | -0.79 % |
 Medtronic plc.
|
MDT | 88.46 (20.09.2022) | -1.36 % |
 Merck & Co., Inc.
|
MRK | 86 (20.09.2022) | -0.74 % |
 Moderna, Inc.
|
MRNA | 129.705 (20.09.2022) | 1.41 % |
 Novartis AG
|
NVS | 79.58 (20.09.2022) | -1.42 % |
|
Novavax, Inc.
|
NVAX | 27.46 (20.09.2022) | -3.41 % |
 ObsEva SA
|
OBSV | 0.1601 (20.09.2022) | 0.00 % |
 OrganiGram Holdings Inc.
|
OGI | 0.9616 (20.09.2022) | -3.84 % |
 Pfizer Inc.
|
PFE | 44.77 (20.09.2022) | -1.47 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 704.22 (20.09.2022) | -1.55 % |
 Sanofi
|
SNY | 39.94 (20.09.2022) | -1.60 % |
 Schrodinger, Inc.
|
SDGR | 26.81 (20.09.2022) | -2.12 % |
 Senseonics Holdings, Inc.
|
SENS | 1.42 (20.09.2022) | -4.05 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 1.73 (20.09.2022) | -2.81 % |
 Stryker Corp.
|
SYK | 217.96 (20.09.2022) | -1.32 % |
 Sundial Growers Inc.
|
SNDL | 2.52 (20.09.2022) | -2.70 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.42 (20.09.2022) | -2.88 % |
 Thermo Fisher Scientific Inc.
|
TMO | 532.16 (20.09.2022) | -1.39 % |
 Tilray, Inc.
|
TLRY | 3.08 (20.09.2022) | -4.35 % |
 UnitedHealth Group, Inc.
|
UNH | 522.8 (20.09.2022) | -0.14 % |
 Veeva Systems Inc.
|
VEEV | 168.04 (20.09.2022) | -2.61 % |
|
Zomedica Corp.
|
ZOM | 0.2301 (20.09.2022) | -4.13 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 0.9904 (20.09.2022) | -7.44 % |
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.